Product Introduction: CLOPINOX-A 150

CLOPINOX-A 150 is a potent antiplatelet cardiovascular medication manufactured by Leeford. Combining 75mg of Clopidogrel and 150mg of Aspirin, it is designed for secondary prevention of atherothrombotic events. This combination works to prevent blood clots in hardened blood vessels, reducing the risk of recurrent strokes, heart attacks, and cardiovascular events.

Primary Clinical Uses

• Prevention of vascular ischemic events in patients with coronary artery disease (CAD).
• Management of acute coronary syndrome (ACS), including unstable angina and myocardial infarction.
• Maintenance therapy in patients post-coronary stent implantation.

Therapeutic Benefits

• Synergistic Action: Dual mechanism prevents platelet aggregation through complementary biological pathways.
• Reduced Thrombosis: Lowers the risk of blood clot formation in cardiac stents.
• Proven Combination: Widely trusted formulation for post-angioplasty care.

Possible Side Effects

Common side effects may include:

• Dyspepsia, heartburn, abdominal pain, or nausea.
• Increased bleeding tendencies, bruising, or nosebleeds.
• Gastrointestinal bleeding (manifested as black or tarry stools).

How to Take CLOPINOX-A 150

• Take one tablet daily, preferably with or immediately after food to reduce gastric discomfort.
• Swallow the tablet whole with water. Do not crush or chew.
• Avoid alcohol, as it can increase the risk of stomach irritation and bleeding.

Mechanism of Action

CLOPINOX-A 150 works through two antiplatelet pathways:

• Clopidogrel: Selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet P2Y12 receptor, preventing ADP-mediated activation of the glycoprotein IIb/IIIa complex.
• Aspirin: Irreversibly inhibits cyclooxygenase-1 (COX-1), blocking the production of thromboxane A2 (a chemical that triggers platelet aggregation).

Safety Warnings

• Bleeding Risk: Use with extreme caution in patients with active peptic ulcers, intracranial hemorrhage, or bleeding disorders.
• Pregnancy & Nursing: Not recommended unless specifically advised by a cardiologist.
• Surgery: Discontinue the medication 5-7 days before scheduled elective surgeries (under your physician's guidance).

Patient Tips

• Notify all healthcare providers (including dentists) that you are taking this antiplatelet medication.
• Be careful when using sharp tools to avoid cuts and bruises.
• Report any unexplained blood in the urine, stool, or sputum immediately to your doctor.

Fact Sheet

Drug Interactions

• NSAIDs (Ibuprofen, Naproxen): Increase the risk of gastrointestinal bleeding.
• Proton Pump Inhibitors (Omeprazole): May reduce Clopidogrel's antiplatelet activity.
• Oral Anticoagulants (Warfarin): Elevates risk of major bleeding events.

User Feedback

• Cardiology patients report that this tablet is highly effective in maintaining stent patency and preventing post-procedure blood clots.
• Some mention the need to take it with a light meal to prevent mild heartburn.